Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Omega Therapeutics
Omega Therapeutics to Present Multiple Posters Highlighting Versatile Platform Capabilities at Upcoming Scientific Meetings
October 15, 2024
From
Omega Therapeutics
Via
GlobeNewswire
Tickers
OMGA
Omega Therapeutics Announces Publication of Epigenomic Controller OTX-2002 Preclinical Data in Nature Communications
September 17, 2024
From
Omega Therapeutics
Via
GlobeNewswire
Tickers
OMGA
Omega Therapeutics Announces Jennifer Nelson, Ph.D., as Senior Vice President of Research
August 14, 2024
From
Omega Therapeutics
Via
GlobeNewswire
Tickers
OMGA
Omega Therapeutics Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress
August 06, 2024
From
Omega Therapeutics
Via
GlobeNewswire
Tickers
OMGA
Omega Therapeutics Announces Election of Richard N. Kender to Board of Directors
June 24, 2024
From
Omega Therapeutics
Via
GlobeNewswire
Tickers
OMGA
Omega Therapeutics To Participate In Two Upcoming Investor Conferences
May 30, 2024
From
Omega Therapeutics
Via
GlobeNewswire
Tickers
OMGA
Omega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business Officer
May 29, 2024
From
Omega Therapeutics
Via
GlobeNewswire
Tickers
OMGA
Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic Controllers
May 08, 2024
From
Omega Therapeutics
Via
GlobeNewswire
Tickers
OMGA
Omega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
May 06, 2024
From
Omega Therapeutics
Via
GlobeNewswire
Tickers
OMGA
Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual Meeting
April 23, 2024
From
Omega Therapeutics
Via
GlobeNewswire
Tickers
OMGA
Omega Therapeutics Presents New Preclinical Data at AACR 2024 Supporting the Potential of Precision Epigenomic Control
April 09, 2024
From
Omega Therapeutics
Via
GlobeNewswire
Tickers
OMGA
Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic Update
March 28, 2024
From
Omega Therapeutics
Via
GlobeNewswire
Tickers
OMGA
Omega Therapeutics Announces Two Poster Presentations at the American Association for Cancer Research Annual Meeting 2024
March 06, 2024
From
Omega Therapeutics
Via
GlobeNewswire
Tickers
OMGA
Omega Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 02, 2024
From
Omega Therapeutics
Via
GlobeNewswire
Tickers
OMGA
Omega Therapeutics to Participate in the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference
December 04, 2023
From
Omega Therapeutics
Via
GlobeNewswire
Tickers
OMGA
Omega Therapeutics to Participate in the Piper Sandler 35th Annual Healthcare Conference
November 20, 2023
From
Omega Therapeutics
Via
GlobeNewswire
Tickers
OMGA
Omega Therapeutics Showcases Bidirectional and Multiplexed Epigenomic Control of Gene Expression in Preclinical Models of Liver Inflammation and Fibrosis
November 13, 2023
From
Omega Therapeutics
Via
GlobeNewswire
Tickers
OMGA
Omega Therapeutics Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress
November 09, 2023
From
Omega Therapeutics
Via
GlobeNewswire
Tickers
OMGA
Omega Therapeutics to Participate in The Jefferies London Healthcare Conference
November 07, 2023
From
Omega Therapeutics
Via
GlobeNewswire
Tickers
OMGA
Omega Therapeutics Presents New Preclinical Data Demonstrating Pre-Transcriptional Modulation of Multiple CXCL Genes by a Single Epigenomic Controller
October 31, 2023
From
Omega Therapeutics
Via
GlobeNewswire
Tickers
OMGA
Omega Therapeutics Presents New Preclinical Data Supporting the Potential of OTX-2101 in Combination Settings for Treatment of NSCLC
October 16, 2023
From
Omega Therapeutics
Via
GlobeNewswire
Tickers
OMGA
Omega Therapeutics Announces Two Poster Presentations on Liver Inflammation and Fibrosis at AASLD’s The Liver Meeting® 2023
October 11, 2023
From
Omega Therapeutics
Via
GlobeNewswire
Tickers
OMGA
Omega Therapeutics to Present New Preclinical Data on OTX-2101 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 04, 2023
From
Omega Therapeutics
Via
GlobeNewswire
Tickers
OMGA
Omega Therapeutics Announces Promising Preliminary Clinical Data for OTX-2002 from Ongoing MYCHELANGELO™ I Trial
September 26, 2023
From
Omega Therapeutics
Via
GlobeNewswire
Tickers
OMGA
Omega Therapeutics to Host Conference Call to Discuss Preliminary Clinical Data for OTX-2002 from Ongoing MYCHELANGELO™ I Trial on September 26
September 25, 2023
From
Omega Therapeutics
Via
GlobeNewswire
Tickers
OMGA
Omega Therapeutics to Participate in Two Upcoming Investor Conferences
September 21, 2023
From
Omega Therapeutics
Via
GlobeNewswire
Tickers
OMGA
Omega Therapeutics Announces Updates to its Board of Directors
August 29, 2023
From
Omega Therapeutics
Via
GlobeNewswire
Tickers
OMGA
Omega Therapeutics Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress
August 03, 2023
From
Omega Therapeutics
Via
GlobeNewswire
Tickers
OMGA
Omega Therapeutics Appoints Chris Schade to its Board of Directors
July 12, 2023
From
Omega Therapeutics
Via
GlobeNewswire
Tickers
OMGA
Omega Therapeutics to Participate in Two Upcoming Investor Conferences
June 01, 2023
From
Omega Therapeutics
Via
GlobeNewswire
Tickers
OMGA
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit